Standout Papers
Immediate Impact
5 by Nobel laureates 35 from Science/Nature 69 standout
Citing Papers
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Management of ALL in adults: 2024 ELN recommendations from a European expert panel
2024 Standout
Works of Michael J. Mauro being referenced
Ponatinib in Refractory Philadelphia Chromosome–Positive Leukemias
2012 Standout
A Phase 1 Trial of Oral Ponatinib (AP24534) In Patients with Refractory Chronic Myelogenous Leukemia (CML) and Other Hematologic Malignancies: Emerging Safety and Clinical Response Findings
2010
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Michael J. Mauro | 3817 | 2964 | 2059 | 230 | 5.1k | |
| Philipp le Coutre | 3452 | 2631 | 1737 | 153 | 4.7k | |
| Gabriel Étienne | 5151 | 4198 | 2425 | 108 | 6.0k | |
| Gianantonio Rosti | 5567 | 4528 | 2663 | 211 | 6.7k | |
| Charles Chuah | 3405 | 2621 | 1554 | 107 | 4.5k | |
| Joëlle Guilhot | 3377 | 2957 | 1703 | 128 | 4.8k | |
| François‐Xavier Mahon | 5480 | 4381 | 2537 | 204 | 6.8k | |
| Norbert Gattermann | 5499 | 3628 | 1104 | 253 | 7.0k | |
| Susan O’Brien | 4258 | 3395 | 1909 | 73 | 5.7k | |
| Susanne Saußele | 3066 | 2641 | 1373 | 121 | 3.7k | |
| Mary Frances McMullin | 4110 | 4274 | 1445 | 214 | 7.3k |
All Works
Login with ORCID to disown or claim papers
Loading papers...